These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 810778)

  • 1. [12 years of Melphalan therapy in a case of Igu-lambda plasmacytoma and resulting therapeutic suggestions].
    Snigurowicz J; Rostkowska J; Slomkowski M; Sielczak M; Kraj M; Krzemińska-Lawkowiczowa I
    Pol Arch Med Wewn; 1975 Oct; 54(4):369-77. PubMed ID: 810778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interim results of the combination of M2 polychemotherapy with calcitonin and synthetic anabolic agents in the treatment of plasmacytoma].
    Fremiotti A; Castellani R; Barbatano L; Salerno L; Bartolini M
    Recenti Prog Med; 1979 Apr; 66(4):418-26. PubMed ID: 113855
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of plasmacytoma].
    Rieche K; Matthes ML
    Dtsch Med Wochenschr; 1972 Apr; 97(15):632. PubMed ID: 5026800
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of plasmacytoma].
    Danieli G; Corvetta A; Leoni P; Montillo M; Collina A
    Minerva Med; 1978 Jun; 69(30):2023-34. PubMed ID: 683564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma].
    Hegenbart U; Goldschmidt H
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1187. PubMed ID: 7656858
    [No Abstract]   [Full Text] [Related]  

  • 6. Extramedullary plasmacytoma of the jejunum.
    Tsuruda T; Ohashi T; Uezono S; Kato J; Nagatomo Y; Sakata J; Haraguchi Y; Eto T
    Intern Med; 1996 May; 35(5):422-6. PubMed ID: 8797062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of extramedullary plasmacytoma of the stomach].
    Fujino R; Ikuno F; Kimura F; Miki H
    Gan No Rinsho; 1984 Jan; 30(1):70-4. PubMed ID: 6422103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells.
    Schwartz RC; Sonenshein GE; Bothwell A; Gefter ML
    J Immunol; 1981 Jun; 126(6):2104-8. PubMed ID: 6164720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing anaplasia of an extramedullary plasmacytoma with loss of detectable paraproteinemia (author's transl)].
    Pudill R; Bettges G; Metz K
    Immun Infekt; 1982 May; 10(3):115-7. PubMed ID: 6807828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intermittent tosstherapy of plasmacytoma with melphalan and predniso(lo)ne].
    Braun HJ
    Minerva Med; 1973 Mar; 64(14):679-82. PubMed ID: 4575093
    [No Abstract]   [Full Text] [Related]  

  • 11. [Systemic light-chain disease as a complication of plasmacytoma].
    Grussendorf M; Grussendorf M; Waldherr R; Seelig HP; Ritz E
    Dtsch Med Wochenschr; 1984 Sep; 109(37):1405-9. PubMed ID: 6434278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of paraproteinemic hemoblastoses].
    Fereberger W
    Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of plasmocytic reticuloma treated periodically with big doses of alkeran and encorton (author's transl)].
    Bradowska M; Uransińki I
    Przegl Lek; 1975; 32(4):427-8. PubMed ID: 1129520
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulation of antitumor response by chemotherapy.
    Ben-Efraim S
    Contrib Gynecol Obstet; 1985; 14():199-205. PubMed ID: 2933224
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of low-dose melphalan treatment against a nonimmunogenic primary induced mouse plasmacytoma.
    Ophir R; Pick AI; Ben-Efraim S
    Anticancer Res; 1987; 7(1):91-6. PubMed ID: 3566188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malabsorption syndrome with IgG(lambda) M component: response to chemotherapy.
    Prokipchuk EJ; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):922-4. PubMed ID: 817794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with lambda type light-chain disease associated with Crow-Fukase syndrome and autoimmune thrombocytopenia].
    Honda Y; Murai I; Aramaki M; Shoji H; Oizumi K
    Rinsho Shinkeigaku; 1991 Nov; 31(11):1248-51. PubMed ID: 1813198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generalized IgG-lambda plasmocytoma and stenosis of a Cimino shunt caused by plasma cell infiltration].
    Reuss-Borst MA; Jacki S; Horny HP; Waller HD
    Dtsch Med Wochenschr; 1994 Dec; 119(49):1694-8. PubMed ID: 7988375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
    Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
    Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status of the therapy of plasmacytomas (treatment with melphalan)].
    Maroncelli P; Pratesi G; Casalino C; Barbatano L
    Recenti Prog Med; 1968 Sep; 45(3):LI-LXVI. PubMed ID: 4192432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.